Gene · 10666
Papers4,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High lymphocyte signature genes expression in parathyroid endocrine cells and its downregulation linked to tumorigenesis. | EBioMedicine | 2024 | 38471398 | PubTator, text mining | PubMed |
| CD155/PVR determines acute myeloid leukemia targeting by Delta One T cells. | Blood | 2024 | 38437507 | PubTator, text mining | PubMed |
| Increased levels of circulating soluble CD226 in multiple sclerosis. | Mult Scler | 2024 | 38424741 | PubTator, text mining | PubMed |
| Altered CD226/TIGIT expressions were associated with NK phenotypes in primary antiphospholipid syndrome and affected by IL-4/JAK pathway. | Clin Exp Immunol | 2024 | 38386917 | PubTator, text mining | PubMed |
| Anti-PD-1 therapy reverses TIGIT+CD226+NK depletion in immunotherapy resistance of hepatocellular carcinoma through PVR/TIGIT pathway. | Int Immunopharmacol | 2024 | 38368771 | PubTator, text mining | PubMed |
| Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients. | BMC Immunol | 2024 | 38326745 | PubTator, text mining | PubMed |
| Ssu72: a versatile protein with functions in transcription and beyond. | Front Mol Biosci | 2024 | 38304578 | PubTator, text mining | PubMed |
| γδ T cells mediate robust anti-HIV functions during antiretroviral therapy regardless of immune checkpoint expression. | Clin Transl Immunology | 2024 | 38299190 | PubTator, text mining | PubMed |
| Essential role of CD155 glycosylation in functional binding to DNAM-1 on natural killer cells. | Int Immunol | 2024 | 38289706 | PubTator, text mining | PubMed |
| Combining TIGIT blockade with IL-15 stimulation is a promising immunotherapy strategy for lung adenocarcinoma. | Clin Transl Med | 2024 | 38279870 | PubTator, text mining | PubMed |
| CAR NK92 Cells Targeting BCMA Can Effectively Kill Multiple Myeloma Cells Both In Vitro and In Vivo. | Biomedicines | 2024 | 38275419 | PubTator, text mining | PubMed |
| TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress. | Mol Biol Rep | 2024 | 38270700 | PubTator, text mining | PubMed |
| Sufficiently activated mature natural killer cells derived from peripheral blood mononuclear cells substantially enhance antitumor activity. | Immun Inflamm Dis | 2024 | 38270321 | PubTator, text mining | PubMed |
| Co-expression of IL-21-Enhanced NKG2D CAR-NK cell therapy for lung cancer. | BMC Cancer | 2024 | 38263004 | PubTator, text mining | PubMed |
| Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy. | Molecules | 2024 | 38257366 | PubTator, text mining | PubMed |
| p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy. | Cancers (Basel) | 2024 | 38254747 | PubTator, text mining | PubMed |
| Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs. | Exp Hematol Oncol | 2024 | 38254219 | PubTator, text mining | PubMed |
| The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia. | Cell Commun Signal | 2024 | 38254135 | PubTator, text mining | PubMed |
| A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. | Nat Commun | 2024 | 38253555 | PubTator, text mining | PubMed |
| Development of Innate-Immune-Cell-Based Immunotherapy for Adult T-Cell Leukemia-Lymphoma. | Cells | 2024 | 38247820 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10666/papers?page=14